The page you requested does not exist. For your convenience, a search was performed below using the query products radioisotopes uranium 235.
ANSTO’s Radioanalytical Chemistry (RAC) facility combines techniques in radiochemistry and radiological measurement by alpha spectrometry, gamma-ray spectrometry, and liquid scintillation analysis to deliver radiological assessments.
Australia has one multi-purpose nuclear reactor, the Open Pool Light Water Reactor (OPAL) and it is not used to generate ‘nuclear power’.
ANSTO has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99 (Mo-99), with less enrichment of uranium-235 (U-235) and produce less waste.
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
The final report on the safety of Building 23 by the independent expert review team has been completed.
ANSTO provides access to specialised facilities and capabilities by application. Please ensure that you contact the relevant ANSTO scientist for advice before submitting a proposal.
ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.
Accelerator Mass Spectrometry (AMS) is an ultra-sensitive analytical technique based on the use of an ion accelerator as a powerful mass spectrometer.
Pagination